Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Mallinckrodt plc

MNKAMEX
Healthcare
Drug Manufacturers - Specialty & Generic
$0.34
$-0.06(-14.97%)
U.S. Market is Open • 12:49

Mallinckrodt plc Fundamental Analysis

Mallinckrodt plc (MNK) shows moderate financial fundamentals with a PE ratio of 0.05, profit margin of 8.64%, and ROE of 10.92%. The company generates $1.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position9536.37%
PEG Ratio-0.00
Current Ratio3.23

Areas of Concern

Operating Margin-8.29%
We analyze MNK's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 44.1/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

D
44.1/100

We analyze MNK's fundamental strength across five key dimensions:

Efficiency Score

Weak

MNK struggles to generate sufficient returns from assets.

ROA > 10%
2.60%

Valuation Score

Excellent

MNK trades at attractive valuation levels.

PE < 25
0.05
PEG Ratio < 2
-0.00

Growth Score

Weak

MNK faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

MNK shows balanced financial health with some risks.

Debt/Equity < 1
1.18
Current Ratio > 1
3.23

Profitability Score

Weak

MNK struggles to sustain strong margins.

ROE > 15%
10.92%
Net Margin ≥ 15%
8.64%
Positive Free Cash Flow
No

Key Financial Metrics

Is MNK Expensive or Cheap?

P/E Ratio

MNK trades at 0.05 times earnings. This suggests potential undervaluation.

0.05

PEG Ratio

When adjusting for growth, MNK's PEG of -0.00 indicates potential undervaluation.

-0.00

Price to Book

The market values Mallinckrodt plc at 0.00 times its book value. This may indicate undervaluation.

0.00

EV/EBITDA

Enterprise value stands at -3.60 times EBITDA. This is generally considered low.

-3.60

How Well Does MNK Make Money?

Net Profit Margin

For every $100 in sales, Mallinckrodt plc keeps $8.64 as profit after all expenses.

8.64%

Operating Margin

Core operations generate -8.29 in profit for every $100 in revenue, before interest and taxes.

-8.29%

ROE

Management delivers $10.92 in profit for every $100 of shareholder equity.

10.92%

ROA

Mallinckrodt plc generates $2.60 in profit for every $100 in assets, demonstrating efficient asset deployment.

2.60%

Following the Money - Real Cash Generation

Operating Cash Flow

Mallinckrodt plc generates limited operating cash flow of $56.90M, signaling weaker underlying cash strength.

$56.90M

Free Cash Flow

Mallinckrodt plc generates weak or negative free cash flow of $-2.55M, restricting financial flexibility.

$-2.55M

FCF Per Share

Each share generates $-0.19 in free cash annually.

$-0.19

FCF Yield

MNK converts -1.37% of its market value into free cash.

-1.37%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

0.05

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.003

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.002

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

1.18

vs 25 benchmark

Current Ratio

Current assets to current liabilities

3.23

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.11

vs 25 benchmark

ROA

Return on assets percentage

0.03

vs 25 benchmark

ROCE

Return on capital employed

-0.03

vs 25 benchmark

How MNK Stacks Against Its Sector Peers

MetricMNK ValueSector AveragePerformance
P/E Ratio0.0529.43 Better (Cheaper)
ROE10.92%800.00% Weak
Net Margin8.64%-20145.00% (disorted) Weak
Debt/Equity1.180.30 Weak (High Leverage)
Current Ratio3.234.64 Strong Liquidity
ROA2.60%-17936.00% (disorted) Weak

MNK outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Mallinckrodt plc's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ